Our ranking of biotech's top translational researchers (Table 1) is based on total patents (US and Europe) granted in 2017; the most-cited patent for the past five years; and the H-index, a method for determining the impact of a scientist's body of published work (higher means more impact). Robert Langer, of MIT, is again at the top; UPenn's James Wilson moved up eight places from 2016; UT Southwestern's Joseph Ready joins the list, as do a trio of researchers from the University of Tokyo. MIT's Feng Zhang dominates the ranking of most-cited patents (Table 2), with CRISPR contributing to nucleic acid therapy as the biggest focus for most-cited patents (Fig. 1).
About this article
Cite this article
Huggett, B., Paisner, K. Top 20 translational researchers of 2017. Nat Biotechnol 36, 798 (2018). https://doi.org/10.1038/nbt.4237
Expert Opinion on Drug Discovery (2019)